Časopisy
SEDLAK, F., A. KVASNIČKA, B. MARESOVA, R. BRUMAROVÁ, D. DOBEŠOVÁ, K. DOSTALOVA, K. SRAMKOVA, M. PEHR, P. SACHA, D. FRIEDECKÝ, J. KONVALINKA
TERNEROVA, N., M. HOUDOVÁ MEGOVÁ, T. BUNA, T. SVABLOVA, B. VYMOLOVA, E. BALAZIOVA, Z. VANICKOVA, E. KREPELA, P. HRABAL, R. TOMAS, D. NETUKA, P. BUSEK, A. SEDO
Fibroblast Activation Protein Expressing Mesenchymal Cells Influence T Cell Abundance and Function in Gliobastoma. Neuro-Oncology. 2024, 26, V35-V36, ISSN: 1522-8517, PDF.
BRIZA, T., J. KRALOVA, B. DOLENSKY, S. RIMPELOVA, Z. KEJIK, T. RUML, M. HAJDÚCH, P. DŽUBÁK, I. MIKULA, P. MARTASEK, P. POUCKOVA, V. KRAL
Striking antitumor activity of a methinium system with incorporated quinoxaline unit obtained by spontaneous cyclization. Chembiochem. 2015, 16(4), 555-558, ISSN: 1439-4227, PMID: 25630657,
BURDOVA, A., J. BOUCHAL, S. TAVANDZIS, Z. KOLÁŘ
TMPRSS2-ERG gene fusion in prostate cancer. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2014, 158(4), 502-510, ISSN: 1213-8118, PMID: 25485532,
TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA, S. GURSKÁ, N. RAMPEESA, S. ANUGU, P. DŽUBÁK, M. HAJDÚCH, V. DAS, N. KATARI
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. RSC Advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712,